O’Melveny & Myers LLP advised Eagle Mountain Energy Partners, while Welborn Sullivan Meck & Tooley, P.C. advised TXO Partners on the deal. Eagle Mountain Energy Partners,...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett is advising Stonepeak on the transaction, and O’Melveny & Myers is advising Textainer Group Holdings Limited. Stonepeak announced it has entered into...
You must be a Standard 1 Year member to access this content.
O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Charles Russell Speechlys and Carey Olsen served as legal counsel to Biolog-id. O’Melveny & Myers LLP, Allen &...
You must be a Standard 1 Year member to access this content.
O’Melveny and Grandall represented Rainmed Medical Limited (2297.HK) on the deal. Herbert Smith Freehills has advised Huatai Financial Holdings. Rainmed Medical Limited (2297.HK) announced its US$19...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers, LLP and Parsons Beble & Latimer advised Dragonfly. Skadden, Arps, Slate, Meagher & Flom and Brownstein Hyatt Farber Schreck advised CNTQ. Chapman and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers and Maples and Calder advised Brii Biosciences Limited on the deal. Herbert Smith Freehills has advised Morgan Stanley and UBS. Brii Biosciences Limited...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP advised the underwriters on the deal. UP Fintech Holding Limited (Tiger Brokers) (Nasdaq: TIGR). announced its US$183 Million Follow-on Offering of shares. Tiger Brokers offered...
You must be a Standard 1 Year member to access this content.
